|
|
Article: Boston Sci settles implant recall case; Guidant will plead guilty to two charges of failing to provide the FDA with data.(NEWS)
- Article from:
- Star Tribune (Minneapolis, MN)
- Article date:
- November 7, 2009
CopyrightCOPYRIGHT 2009 Star Tribune Co. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: JANET MOORE; STAFF WRITER
Boston Scientific Corp. said Friday it has reached a $296 million agreement with the U.S. Department of Justice related to a series of product recalls in 2005, ending a wrenching chapter in medical technology that has lingered for more than four years.
In an investigation led by the U.S. attorney's office in Minneapolis, the company's Arden Hills-based subsidiary, Guidant, will plead guilty to two misdemeanor charges for "failure to include information" in reports to the Food and Drug Administration (FDA), which regulates medical devices and recalls them if they are found to be faulty.
That was the case in 2005 ...